Sodium oxamate inhibits lactate dehydrogenase(LDH)and is an inhibitor of gluconeogenesis and glycolysis.
Sodium oxamate is an inhibitor of gluconeogenesis and glycolysis. It is a structural analog of pyruvate, inhibits L(+)-lactate dehydrogenase and derails the entire gluconeogenic pathway. As cancer cells are often dependent on glycolysis for ATP production, sodium oxamate has implications as an anticancer compound.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Phedias Diamandis et. Al. Nature Chemical Biology, 3(5), 268-273 (2007)
[2] T H Hereng et. Al. Human Reproduction, 26(12), 3249-3263 (2011)
[3] S Fujiwara et. Al. British Journal of Cancer, 108(1), 170-178 (2013)
[4] Yi Zhou et. Al. Oncology Reports, 35(3), 1573-1581 (2016)
分子式 565-73-1 |
分子量 111.03 |
CAS号 565-73-1 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO <1 mg/mL |
Water 10 mg/mL |
Ethanol <1 mg/mL |
体内溶解度
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们